In two Phase I trials, researchers safely administered CAR T cells to high-grade glioma patients and are exploring ways to ...

NEW YORK – Galapagos on Tuesday said that after a strategic review it has decided to wind down its cell therapy business, which includes several CAR T-cell therapies in development for blood cancers ...

In this tough-to-treat cancer type, more patients receiving anzu-cel saw their tumors shrink and had durable responses than what's been seen with other therapies.

The Sweden-based Phase II trial will evaluate how well the company's gallium-68-labeled PET tracer identifies best responders to Enhertu.

The firm will launch a Phase I trial in healthy volunteers in the Netherlands to establish safety and proof-of-target engagement.

While Natera said it will seek FDA approval for Signatera based on data from IMvigor011, the readout from another ctDNA-guided de-escalation study was more nuanced.

The company will hold off on making a regulatory decision until it sees results from another trial testing the drug with ...

In a Phase III trial, sacituzumab tirumotecan outperformed chemo in previously treated EGFR-mutant NSCLC patients, results presented at the ESMO Congress show.

NEW YORK – Taysha Gene Therapies has regained full rights to its lead program, TSHA-102, for Rett syndrome after an option agreement with Astellas expired.

The registrational trial of AD04 could launch as early as mid-2026, if the company is able to shore up necessary funds or ...

The new funds will allow the company to test its multi-node PI3K treatment approach in a new endometrial cancer trial.

As Novartis moves ahead plans to expand Pluvicto's use based on the PSMAddition trial, experts urge for greater use of ...